Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$52.8M
-73.2% from 2023
Prescriptions
4,123
$12,816.79 per claim
Patients
1,778
496 prescribers
Total spending, 2024
$52.8M
$29,720.82 per patient
Medicare prescription drug plans paid $52.8M for Relyvrio in 2024, for 4,123 prescriptions and refills to 1,778 patients (down 73.2% from 2023). The average cost per claim was $12,816.79.
New York had the highest Medicare cost for Relyvrio in 2024: $5.1M for 403 claims, followed by California ($5.1M).
Matthew B Harms, neurology in New York, NY, had the highest Medicare cost for Relyvrio in 2024: 59 claims costing $766K.
Relyvrio is made by Amylyx Pharmaceuticals, Inc. (AMLX), listed in the Medicare spending data as Amylyx Pharmace.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Matthew B Harms New York, NY | Neurology | 59 | 26 | $766K |
| Ginna Gonzalez Miami, FL | Nurse Practitioner | 57 | 23 | $724K |
| Kelly G Gwathmey New York, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 245 | 981 | 667 | $9.9M |
| 2023 | 629 | 15,794 | 3,316 | $197.4M |
| 2024 | 496 | 4,123 | 1,778 | $52.8M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 51 |
| 23 |
| $620K |
| Melissa L Warren Woodbury, NJ | Nurse Practitioner | 46 | 19 | $573K |
| Merit E Cudkowicz Boston, MA | Neurology | 42 | 20 | $544K |
| Kelly White Durham, NC | Physician Assistant | 40 | 19 | $524K |
| James D Berry Boston, MA | Neurology | 40 | 17 | $520K |
| Ikjae Lee New York, NY | Neurology | 42 | 16 | $514K |
| Daragh Heitzman Dallas, TX | Neurology | 40 | 17 | $494K |
| Zachary Simmons Hershey, PA | Neurology | 38 | 16 | $472K |
| James P Wymer Gainesville, FL | Neurology | 36 | 17 | $441K |
| Bjorn Oskarsson Jacksonville, FL | Neurology | 34 | 12 | $434K |
| Stephen Scelsa New York, NY | Neurology | 36 | 15 | $434K |
| Tulio Bertorini Memphis, TN | Neurology | 32 | 16 | $415K |
| Doreen T Ho Burlington, MA | Neurology | 33 | 16 | $413K |
| Xiaoyan Li Durham, NC | Neurology | 33 | 15 | $411K |
| Michael A Elliott Seattle, WA | Neurology | 30 | 14 | $408K |
| Mark Garret Lebanon, NH | Neurology | 33 | 15 | $404K |
| Gabriela Lopes Fort Lauderdale, FL | Nurse Practitioner | 31 | 12 | $394K |
| Jourdan D Milliard Phoenix, AZ | Nurse Practitioner | 30 | 12 | $387K |
| John C Novak Westerville, OH | Neurology | 30 | 11 | $382K |
| Tawfiq Al Lahham Pittsburgh, PA | Neurology | 28 | 12 | $369K |
| Ning Wu Hershey, PA | Neurology | 29 | Under 11 | $367K |
| Simona Treidler Stony Brook, NY | Neurology | 29 | 12 | $367K |
| Jinsy Andrews New York, NY | Neurology | 30 | 13 | $364K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Amylyx Pharmace AMLX | 4,123 | $52.8M |